🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07825428
Starting soon Not applicable

AI-Stratified Myopia Control for Children in Remote Areas

NCT07825428 · tracked via the Priya Life Science China tracker
Sponsor
Shanghai Eye Disease Prevention and Treatment Center
Phase
Not applicable
Started
2026-09-01
Last updated
2026-09-17

Condition(s) studied

Myopia

Investigational drug(s) / intervention(s)

Routine Screening and ReferralAI-Guided Tiered Management

Routine Screening and Referral: Based on routine screening combining uncorrected visual acuity with non-cycloplegic autorefraction and axial length, the control group provides parents with screening reports, feedback, and referrals according to the national health industry standard, which provides tiered recommendations ranging from routine monitoring and eye hygiene, to ophthalmologic consultation for those at risk of myopia, to regular 3- to 6-month re-examination for those with reduced uncorrected but normal corrected visual acuity, and to timely referral for those identified as screening-positive or with possible visual function abnormalities.

AI-Guided Tiered Management: Students in the intervention group receive routine vision screening followed by AI-based risk stratification, which classifies each student into one of three categories, hyperopia, pre-myopia, or myopia, to guide subsequent tiered interventions. For children with hyperopia, the intervention consists of prescribed outdoor activities, with a target of 2 hours per day on weekends and daily activity records. For those with pre-myopia, the intervention combines plano defocus lenses (A.M.L.™) worn for at least 8 hours per day with the same outdoor activity regimen. For those with myopia, the intervention includes defocus lenses (A.M.L.™) worn for at least 12 hours per day, also combined with outdoor activities and records. All tiered assignments are dynamically adjusted at each follow-up visit based on the most recent AI classification.

Study summary

This cluster-randomized controlled trial aims to evaluate the effectiveness and cost-effectiveness of an artificial intelligence-based, risk-stratified, tiered intervention model for childhood myopia prevention and control in resource-limited county areas of China, compared with the conventional screening-and-referral approach, with schools in project counties of Guizhou or Yunnan Province randomly assigned at a 1:1 ratio to either the intervention or control group over a 12-month follow-up period.

The study is motivated by the pressing reality that myopia among Chinese children is not only widespread but also occurring at younger ages than ever before, bringing with it a lifelong risk of sight-threatening complications, yet in remote county areas, routine vision screening programs are not yet widely available or well-established, due to a shortage of trained eye care professionals, the practical difficulties of performing cycloplegic refraction in school settings, and the lack of systematic follow-up, all of which make it hard to identify children with myopia or pre-myopia. Given that artificial intelligence may offer a practical way to assess risk without the need for pupil dilation, this study will enroll children in grades 1 through 3 from local primary schools. Over 12 months, an AI model will dynamically categorize children based on screening results and guide management adjustments(outdoor activity and defocus lenses) for the intervention group, while the control group receives routine care.

The findings are expected to provide evidence to inform and optimize AI-based myopia prevention and control strategies in remote areas.

Eligibility

Sex
ALL
Min age
6 Years
Max age
9 Years
Healthy volunteers
Accepted
1. School level: Inclusion Criteria: * The school is a regular public primary school located within a project county in Guizhou Province or Yunnan Province. * The school has the organizational capacity to conduct myopia screening and follow-up studies in children and adolescents, including the ability to coordinate screening organization, parent communication, informed consent collection, result feedback, and follow-up coordination. * The number of students in grades 1-3 in study school is sufficient to meet the requirements for conducting a cluster randomized study. Exclusion Criteria: * The school has implemented a similar systematic myopia intervention program within the past year that may affect the evaluation of study outcomes. * Student mobility is high, with a predicted high risk of transfer, missed visits, or loss to follow-up within 12 months. * There is a lack of accessible medical institutions near the school to support necessary cycloplegic examinations and related services. 2. Participant level: Inclusion Criteria: * Age of participants is 6-9 years (equivalent to grades 1-3 of primary school). * Participants can be able to complete baseline and follow-up examinations including visual acuity, non-cycloplegic autorefraction, and axial length measurements. * For participants who have previously received myopia control interventions such as low-dose atropine eye drops, defocus spectacle lenses, or red-light therapy, a washout period of at least 1 month is required prior to enrollment. Exclusion Criteria: * Baseline spherical equivalent refraction (SER) ≤ -10.00 D. * Presence of ocular or systemic diseases (including infections) that may affect visual acuity or refraction, or use of systemic or topical medications that may alter ocular status or affect ocular health. * Presence of any ocular conditions that preclude suitability for the interventions in this study, including but not limited to amblyopia, manifest strabismus, or current use of orthokeratology lenses. * Presence of any other condition that, in the investigator's judgment, makes the participant unsuitable for enrollment.

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
The Affiliated Hospital of Guizhou Medical University Guiyang Guizhou
Shanghai Eye Disease Prevention & Treatment Center Shanghai Shanghai Municipality
The First Affiliated Hospital of Kunming Medical University Kunming Yunnan

More Shanghai Eye Disease Prevention and Treatment Center trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07825428 on ClinicalTrials.gov ↗ ← All trials in China